Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Patent Law

: Patent Docs

Biotech/Pharma Lobbying Scoreboard - Second Quarter Update - Part II

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

ADVERTISEMENTS

By Donald Zuhn -- Last month, we reported on the lobbying expenditures for fourteen biotech and pharma companies and organizations in the second quarter of 2008. Recent news reports have allowed us to add four more companies to the list: ? Sanofi-Aventis' U.S. subsidiary spent more than $1.2 million on second quarter lobbying (see Forbes.com report). According to Sanofi-Aventis' July 18 filing with the House clerk's office, the drugmaker's lobbying efforts were directed in part at follow-on biologics legislation. In addition, the company's vaccine division spent $460,000 lobbying in part on patent reform. ? Teva Pharmaceutical Industries Inc. spent $490,000...

Full post as published by Patent Docs on September 13, 2008 (boomark / email).

Lawsuits and Settlements

Medical Records
To Stay out of Pharma's Hands

FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review

UPDATE 1: Caraco Digoxin Recall

Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

Intuit
allegedly sent out a defective QuickBooks Pro update.

Mexican Vanilla Containing Coumarin
, FDA Issues Consumer Update

Related Searches